Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence

Venous thromboembolic disease (VTED) is a common and clinically important complication in patients with cancer, contributing to its mortality and morbidity. Direct oral anticoagulant agents (DOACs), including direct thrombin inhibitors and direct factor Xa inhibitors, are as effective as vitamin K a...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Escobar, I., Brozos-Vázquez, E., Gutierrez Abad, D., Martínez-Marín, V., Pachón, V., Muñoz Martín, A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084841/
https://www.ncbi.nlm.nih.gov/pubmed/33206333
http://dx.doi.org/10.1007/s12094-020-02506-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084841/
https://www.ncbi.nlm.nih.gov/pubmed/33206333
http://dx.doi.org/10.1007/s12094-020-02506-4

Ejemplares similares